3,4-dihydro-(1H)quinazolin-2-one compounds as CSBP/p38 kinase inhibitors
US7053099B1 · kind B1 · utility
1Cited by
50References
17Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Nov 21, 2000 |
| Grant date | May 30, 2006 |
| Priority date | — |
| Expiry date | Nov 21, 2020 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY02A50/30
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Novel substituted quinazoline compounds and compositions for use in therapy as CSBP/p38 kinase inhibitors.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.